mAbxience
Ivan Sanchez de Melo is an experienced professional in the field of biosimilar therapeutic drugs. With a background in molecular and cellular biology, Ivan has held various managerial roles in research and development within different companies. Ivan is skilled in designing and optimizing UPS&DSP processes, as well as in setting up biosimilar development platforms based on mammalian cell lines. Ivan has also completed executive education programs in leadership and innovation. Ivan's expertise lies in process development and tech transfer, making him a valuable asset in the pharmaceutical industry.
This person is not in any offices
mAbxience
mAbxience is a high growth international biotechnology company specialized in the research, development, manufacture and global commercialization of biopharmaceutical products to treat and prevent diseases across different therapeutic areas.